PURPOSE: The purpose of the study was to report on the prognostic value of (99m)Tc-hydrazinonicotinamide (HYNIC) Annexin-V single-photon emission computed tomography (SPECT) imaging in patients suffering from primary squamous cell carcinoma of the head and neck. METHODS: Twenty-nine patients diagnosed with a primary untreated head and neck squamous cell carcinoma were included in this study. In all patients, (99m)Tc-HYNIC Annexin-V scintigraphy SPECT was performed before treatment instigation. Tumour-to-background ratios (T/N) of the primary tumour, derived from reconstructed images, as well as clinical variables were obtained in all patients and related to patient outcome. Median follow-up was 22.6 months (range 4.1-55.8 months). RESULTS: On univariate as well as multivariate analysis, only the (99m)Tc-HYNIC Annexin-V T/N ratio dichotomized using the group median as cutoff value (T/N ratio of 2) was predictive of recurrence-free survival (respectively, p = 0.0000 and 0.000). On univariate analysis, only lymph node status dichotomized according to N0 vs N1-N2-N3 disease and the (99m)Tc-HYNIC Annexin-V T/N ratio dichotomized using the group median as cutoff value (T/N ratio of 2) were predictive of overall survival (p = 0.0051 and 0.0000). When both factors were included in the multivariate model, both N status and the (99m)Tc-HYNIC Annexin-V T/N ratio showed an independent association with overall survival (p = 0.001 for lymph node status and 0.000 for dichotomized (99m)Tc-HYNIC Annexin-V T/N ratio). CONCLUSION: (99m)Tc-HYNIC Annexin-V T/N ratios derived from SPECT provides independent prognostic information on disease-free survival and overall survival.
PURPOSE: The purpose of the study was to report on the prognostic value of (99m)Tc-hydrazinonicotinamide (HYNIC) Annexin-V single-photon emission computed tomography (SPECT) imaging in patients suffering from primary squamous cell carcinoma of the head and neck. METHODS: Twenty-nine patients diagnosed with a primary untreated head and neck squamous cell carcinoma were included in this study. In all patients, (99m)Tc-HYNICAnnexin-V scintigraphy SPECT was performed before treatment instigation. Tumour-to-background ratios (T/N) of the primary tumour, derived from reconstructed images, as well as clinical variables were obtained in all patients and related to patient outcome. Median follow-up was 22.6 months (range 4.1-55.8 months). RESULTS: On univariate as well as multivariate analysis, only the (99m)Tc-HYNICAnnexin-V T/N ratio dichotomized using the group median as cutoff value (T/N ratio of 2) was predictive of recurrence-free survival (respectively, p = 0.0000 and 0.000). On univariate analysis, only lymph node status dichotomized according to N0 vs N1-N2-N3 disease and the (99m)Tc-HYNICAnnexin-V T/N ratio dichotomized using the group median as cutoff value (T/N ratio of 2) were predictive of overall survival (p = 0.0051 and 0.0000). When both factors were included in the multivariate model, both N status and the (99m)Tc-HYNICAnnexin-V T/N ratio showed an independent association with overall survival (p = 0.001 for lymph node status and 0.000 for dichotomized (99m)Tc-HYNICAnnexin-V T/N ratio). CONCLUSION: (99m)Tc-HYNICAnnexin-V T/N ratios derived from SPECT provides independent prognostic information on disease-free survival and overall survival.
Authors: B R Gastman; Y Atarshi; T E Reichert; T Saito; L Balkir; H Rabinowich; T L Whiteside Journal: Cancer Res Date: 1999-10-15 Impact factor: 12.701
Authors: J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss Journal: Nat Med Date: 2001-12 Impact factor: 53.440
Authors: Christophe van de Wiele; Christophe Lahorte; Hubert Vermeersch; D Loose; Kris Mervillie; Neil D Steinmetz; Jean-Luc Vanderheyden; Claude A Cuvelier; Guido Slegers; Rudi A Dierck Journal: J Clin Oncol Date: 2003-09-15 Impact factor: 44.544
Authors: Tarik Z Belhocine; Francis G Blankenberg; Marina S Kartachova; Larry W Stitt; Jean-Luc Vanderheyden; Frank J P Hoebers; Christophe Van de Wiele Journal: Eur J Nucl Med Mol Imaging Date: 2015-08-16 Impact factor: 9.236
Authors: Bryan A Smith; Walter J Akers; W Matthew Leevy; Andrew J Lampkins; Shuzhang Xiao; William Wolter; Mark A Suckow; Samuel Achilefu; Bradley D Smith Journal: J Am Chem Soc Date: 2010-01-13 Impact factor: 15.419